Godavari Biorefineries Secures Mexican Patent for Viral Infection Treatment Compounds
Godavari Biorefineries Ltd receives a Mexican patent for V-ATPase inhibiting compounds to treat viral infections. Term expires 2041. Market Cap: ₹1,162.62 Cr.
ALFA News
Straight from the exchange filing
Godavari Biorefineries Ltd receives a Mexican patent for V-ATPase inhibiting compounds to treat viral infections. Term expires 2041. Market Cap: ₹1,162.62 Cr.